Women's Health
Adding bevacizumab to chemotherapy does not worsen quality of life in breast cancer subset
The addition of bevacizumab to chemotherapy did not appear to be negatively associated with quality of life at 18 months in lymph node-positive or high-risk lymph node-negative breast cancer, according to a study in JAMA Network Open.
Q&A: Anti-abortion laws and implications for pregnant patients with CVD
As the U.S. Supreme Court prepares to issue a decision that could potentially overturn Roe v. Wade, many states are preparing to restrict or eliminate abortion rights for patients, including those with CVD.
Gene linked to survival after anthracyclines, anti-HER2 therapies for breast cancer
Genetic variants of the UACA gene, a critical regulator of tumor suppressor Par-4, appeared associated with OS among patients who received anthracyclines and HER2-targeted therapy, according to a study published in NPJ Breast Cancer.
Travel distance to facility represents barrier to abortion care in US
Women who lived farther from an abortion facility were more likely to experience delays in obtaining abortion care or were unable to access it, according to data published in JAMA Network Open.
Sexual minority individuals less likely to undergo cervical cancer screening
Individuals who identified as a sexual minority had lower odds of ever undergoing Pap testing compared with heterosexual individuals, according to a study published in Cancer.
Biosimilar comparable to trastuzumab in efficacy for breast cancer subset
HD201, a trastuzumab biosimilar candidate, demonstrated equivalent efficacy to referent trastuzumab among patients with ERBB2-positive early breast cancer, according to phase 3 study results published in JAMA Oncology.
Q&A: Stephanie Faubion, MD, talks goals beyond ‘bikini medicine’ for Women’s Health Week
Each year, National Women’s Health Week emphasizes how important it is for women to prioritize their health.
Decrease in cervical cancer rates may be linked to HPV screening, vaccination
A decrease in cervical cancer rates in the United States, most notably among younger women, may be associated with HPV vaccination approval, according to a retrospective, cross-sectional study published in JAMA Network Open.
VIDEO: Linzagolix is a ‘win-win’ for patients with uterine fibroids
SAN DIEGO — Several abstracts were presented at the ACOG Annual Clinical & Scientific Meeting on the efficacy and safety of linzagolix, an investigational oral GnRH antagonist being developed for the treatment of fibroid-related symptoms.
VIDEO: 'Protect women through research and not from research'
SAN DIEGO — In this video, Cynthia Gyamfi-Bannerman, MD, MS, FACOG, discusses the impact of SARS-CoV-2 on the pregnant population, which was the focus of her presentation at the ACOG Annual Clinical & Scientific Meeting.